The association of protein S Tokushima-K196E with a risk of deep vein thrombosis

被引:25
作者
Ikejiri, Makoto [2 ]
Wada, Hideo [1 ]
Sakamoto, Yuko [2 ]
Ito, Naohiko [1 ]
Nishioka, Junji [2 ]
Nakatani, Kaname [1 ]
Tsuji, Akihiro [3 ]
Yamada, Norikazu [3 ]
Nakamura, Mashio [3 ]
Ito, Masaaki [3 ]
Nobori, Tsutomu [1 ]
机构
[1] Mie Univ, Grad Sch Med, Dept Mol & Lab Med, Tsu, Mie 5148507, Japan
[2] Mie Univ, Grad Sch Med, Cent Lab, Tsu, Mie 5148507, Japan
[3] Mie Univ, Grad Sch Med, Dept Cardiol & Nephrol, Tsu, Mie 5148507, Japan
关键词
Protein S; PS Tokushima; K196E; DVT; C ANTICOAGULANT SYSTEM; COAGULATION-FACTOR-V; JAPANESE PATIENTS; VENOUS THROMBOSIS; GENERAL-POPULATION; DEFICIENCY; PREVALENCE; MUTATIONS; WARFARIN; POLYMORPHISMS;
D O I
10.1007/s12185-010-0671-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Deep vein thrombosis (DVT) is a multifactorial disease caused by acquired risk factors such as a bed rest, surgery and malignancies. Although the factor V Leiden and the prothrombin-20210G > A mutation do not exist in Japanese populations, a mutation in protein S (PS) Tokushima (K196E) has been attracting attention in Japan. In this study, the genetic contribution of PS Tokushima (K196E) was evaluated in 60 Japanese patients with thrombosis in comparison to 234 healthy volunteers and 88 patients without thrombosis. Genes associated with the response to warfarin, cytochrome P450 2C9 (CYP2C9), vitamin K epoxide reductase complex subunit 1 (VKORC1), and gamma-glutamyl carboxylase (GGCX) were also investigated simultaneously. PS Tokushima (K196E) was detected in 6 patients with thrombosis, in 3 without thrombosis and in 3 healthy volunteers, indicating that there is a high frequency of the PS Tokushima (K196E). There were no significant differences of CYP2C9, VKORC1 or GGCX between the patients with and without DVT. Therefore, PS Tokushima (K196E) is an important genetic risk factor for DVT in the Japanese population.
引用
收藏
页码:302 / 305
页数:4
相关论文
共 20 条
[1]   The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population [J].
Beauchamp, NJ ;
Dykes, AC ;
Parikh, N ;
Tait, RC ;
Daly, ME .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (05) :647-654
[2]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[3]  
DAHLBACK B, 1991, THROMB HAEMOSTASIS, V66, P49
[4]   THE PROTEIN-C ANTICOAGULANT SYSTEM - INHERITED DEFECTS AS BASIS FOR VENOUS THROMBOSIS [J].
DAHLBACK, B .
THROMBOSIS RESEARCH, 1995, 77 (01) :1-43
[5]  
Gandrille S, 2000, THROMB HAEMOSTASIS, V84, P918
[6]  
Hamasaki Naotaka, 2008, P597, DOI 10.1007/978-4-431-78847-8_41
[7]   Molecular mechanism of the dysfunction of protein S-Tokushima (Lys(155)->Glu) for the regulation of the blood coagulation system [J].
Hayashi, T ;
Nishioka, J ;
Suzuki, K .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1995, 1272 (03) :159-167
[8]   PROTEIN-S TOKUSHIMA - ABNORMAL-MOLECULE WITH A SUBSTITUTION OF GLU FOR LYS-155 IN THE 2ND EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF PROTEIN-S [J].
HAYASHI, T ;
NISHIOKA, J ;
SHIGEKIYO, T ;
SAITO, S ;
SUZUKI, K .
BLOOD, 1994, 83 (03) :683-690
[9]   Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients [J].
Kimura, R ;
Honda, S ;
Kawasaki, T ;
Tsuji, H ;
Madoiwa, S ;
Sakata, Y ;
Kojima, T ;
Murata, M ;
Nishigami, K ;
Chiku, M ;
Hayashi, T ;
Kokubo, Y ;
Okayama, A ;
Tomoike, H ;
Ikeda, Y ;
Miyata, T .
BLOOD, 2006, 107 (04) :1737-1738
[10]   Genotypes of vitamin K epoxide reductase, γ-glutamyl carboxylase, and cytochrome P4502C9 as determinants of daily warfarin dose in Japanese patients [J].
Kimura, Rina ;
Miyashita, Kotaro ;
Kokubo, Yoshihiro ;
Akaiwa, Yasuhisa ;
Otsubo, Ryoichi ;
Nagatsuka, Kazuyuki ;
Otsuki, Toshiho ;
Okayama, Akira ;
Minematsu, Kazuo ;
Naritomi, Hiroaki ;
Honda, Shigenori ;
Tomoike, Hitonobu ;
Miyata, Toshiyuki .
THROMBOSIS RESEARCH, 2007, 120 (02) :181-186